← Evidence map

TrialBlood2017

Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.

Harold C Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28373263